About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Financial Data and Key Metrics Changes - The company achieved a total revenue growth of 5% quarter-over-quarter, driven mainly by Developer Services revenue [7] - Developer Services revenue decreased by 1% year-over-year but grew by 8% quarter-over-quarter [7] - Subscription services revenues were RMB48.8 million, up 5% year-over-year and quarter-over-quarter [8] - The company recorded a positive adjusted EBITDA for consecutive quarters, marking a historical achievement [17][20] Business Line Data and Key Metrics Changes - Value-added services revenues decreased by 60% year-over-year but increased by 38% quarter-over-quarter [9] - EngageLab business saw a 70% growth in customer sign-ups, reaching over 170 customers, and a 50% growth in commercial contract value to RMB15 million [10][26] - Financial risk management revenue grew by 17% year-over-year, supported by a 26% increase in customer numbers [12] Market Data and Key Metrics Changes - The overseas market, particularly for EngageLab, is identified as a key growth area, with strong demand for products [11][26] - The domestic market is expected to experience stable but relatively low growth [33] Company Strategy and Development Direction - The company aims to continue expanding its EngageLab business globally, particularly in Southeast Asia [26] - Management emphasizes cost control, with operating expenses decreasing by RMB108 million year-over-year, positioning the company for future growth [15][25] Management Comments on Operating Environment and Future Outlook - Management expressed optimism about maintaining positive adjusted EBITDA in 2024, contingent on continued revenue growth [24][25] - The company acknowledges the slower growth in the domestic market but remains focused on international expansion [33] Other Important Information - The company repurchased 53,000 ADS in Q4 2023, totaling 188,000 ADS since the start of the repurchase program [21] Q&A Session Summary Question: Future trend of adjusted EBITDA - Management is optimistic about maintaining positive adjusted EBITDA in 2024, supported by reduced operating expenses and revenue growth [24][25] Question: EngageLab growth expectations and revenue contribution - Management expects continued growth in EngageLab, with a significant increase in customer numbers and contract value, although revenue contribution remains immaterial at this stage [26] Question: New customer accounts and industry trends - New customer growth is broad-based across various industries, with a shift towards outsourcing push notification services [30][31] Question: Impact of the Chinese economy on subscriptions - The domestic market is expected to grow slowly, while overseas markets are driving stronger growth [33] Question: Change in ARPU and growth potential - ARPU increased from RMB8,000 in Q1 2023 to RMB11,000 in Q4 2023, with expectations for continued but slower growth [36][37] Question: Recovery of non-subscription revenues - Financial risk management is expected to continue growing, while market intelligence remains slow due to demand for Chinese ADR data [40] Question: Cash flow sources and divestiture impact - The company received additional cash from a divestiture, which did not impact revenue [41][43] Question: Seasonality of revenue - Q1 is expected to be slow due to Chinese New Year, with stronger performance anticipated in Q2 and Q4 [46][47]

Could These Marijuana Stocks Run Today?More publicly traded cannabis companies are starting to report earnings. This alone has been another reason shareholders have seen a slight increase in trading momentum for marijuana stocks. Speculation is high in 2024 for those who are invested in legal cannabis. Political figures from all parties are starting to find common ground with the cannabis industry.With 2024 being an election year there is even more motivation to figure out how to pass federal reform. The am ...

Ordinarily, you’ll want to avoid excessively red-stained ideas. Although certain exceptions might be made for these oversold stocks ready for rebound. Certain relevant enterprises may be liable to bounce back after bearish actions have gone too far.Whether you want to call them dead-cat bounces or snapback rallies, the principle is the same. After incurring long bouts of negativity, market participants might see value shift to the other side of the equation. Nothing stays perfectly linear forever, which und ...

                                                                        NASDAQ | TSX: ACBCanada's Leading Medical Cannabis Company and MedReleaf Australia Launch Innovative Product to Offer Greater Choice for PatientsEDMONTON, AB, March 4, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced today the availability of medical cannabis pastilles for doctors to prescr ...

 NASDAQ | TSX: ACB EDMONTON, AB, Feb. 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canada-based leading global medical cannabis company, today announced that it has repaid an aggregate of approximately $7.2 million (US$5.3 million), representing the final payment on the principal amount of its convertible senior notes ("Notes") at a total cash cost of $7.4 million (~US$5.5 million), including accrued interest. Following the completion of this repayme ...

                                                                                                        NASDAQ | TSX: ACB Partnership will empower UK patients with valuable information and guidance critical to a successful cannabis experience   EDMONTON, AB, Feb. 28, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, today announced the partnership of Aurora Medicine UK Ltd with Script Assist, a cutting-edge medical cannabis prescri ...

Aleksandr_Kravtsov/iStock via Getty Images Aurora Cannabis (NASDAQ:ACB, ACB:CA) recently completed the consolidation of common shares on a 10:1 basis to maintain its minimum bid requirement to stay on the NASDAQ. This is the second time the company has done a reverse share split, with the first being back on May 11, 2020 on a 12:1 basis. StockCharts I previously suggested the company may turn around in 2023 and I may have been too early. But as absolutely bleak as the stock price chart looks there see ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Marijuana Stocks To Buy Before March BeginsPeople who are involved in cannabis investing are keeping a positive outlook towards the future. Many feel this year will be big for investors and have the potential to see a rise in marijuana stocks. The start of a new year comes with many challenges and opportunities. Much of the obstacles to overcome have to do with better reform measures for legal cannabis operators. What this means is during 2024 many hope to see the end of cannabis prohibition.If cannabis ref ...